# COMPLETION REPORT

## Task 3.1 — Literature Benchmarking
**Status**: Done
**Files changed**: paper/paper_metrics.py, paper/build_paper.py, paper/build_pdf.py
**Verification performed**: Web-searched for real published studies. Confirmed:
- Zeng et al. (2025), World Journal of Clinical Oncology, DOI: 10.3748/wjco.v16.i8.3070 -- SVM/RF/XGB predicting Ki-67 in CRC. External validation AUC 0.750-0.795.
- Agesen et al. (2012), Clinical Cancer Research, DOI: 10.1158/1078-0432.CCR-11-2097 -- ColoGuideEx 13-gene classifier. AUC ~0.710.
- OncoType DX (2010), Journal of Clinical Oncology, DOI: 10.1200/JCO.2009.26.0123 -- RT-qPCR 12-gene signature. AUC ~0.680.
**Flags**: AUC values for ColoGuideEx and OncoType DX are approximate; marked ~approx. in Table 9.

---

## Task 3.2 — Subgroup Interaction Testing
**Status**: Done
**Files changed**: src/complete_analysis.py, paper/paper_metrics.py, paper/build_paper.py, paper/build_pdf.py
**Verification**: Ran python -m src.complete_analysis. Subgroup results:
  Age < 65 vs >= 65: ΔAUC = 0.006, p = 0.5000 (95% CI: -0.013 to 0.030)
  Male vs Female:    ΔAUC = 0.004, p = 0.7160 (95% CI: -0.012 to 0.025)
  Stage I/II vs III/IV: ΔAUC = 0.002, p = 0.8780 (95% CI: -0.016 to 0.027)
No significant interactions (all p > 0.05). Table 6 updated with interaction columns.
**Flags**: None.

---

## Task 3.3 — Validation Design Justification
**Status**: Done
**Files changed**: paper/paper_metrics.py, paper/build_paper.py, paper/build_pdf.py
**Verification**: TCGA 50/50 split confirmed: n=161 calibration, n=161 evaluation. ASCII schematic added to Methods.
**Flags**: Seed 42 used -- should be noted explicitly in paper once.

---

## Task 3.4 — Biological Mechanism Discussion Expansion
**Status**: Done
**Files changed**: paper/paper_metrics.py, paper/build_paper.py, paper/build_pdf.py
**Verification**: Citations verified:
  MCM10: Langston et al., eLife 2017, DOI: 10.7554/eLife.29118 (confirmed real)
  SPC25: Bharadwaj et al., J Cell Biol 2004, DOI: 10.1083/jcb.200403086 (confirmed real)
  NCAPH: Seipold et al., EMBO Reports 2009, DOI: 10.1038/embor.2009.73 (confirmed real)
  RFC4: Overmeer et al., J Biol Chem 2010, DOI: 10.1074/jbc.M109.083981 (confirmed real)
GO pathway terms match results/pathway_enrichment_results.csv.
**Flags**: Author should independently verify DOIs on final proofread.

---

## Task 3.5 — Figure/Table Polish
**Status**: Done
**Files changed**: Figures already at DPI=300 in results/. Copied to paper/figures_final/.
**Verification**: ECE values from results/detailed_model_metrics_with_ci.csv:
  LR=0.0353, RF=0.1052, XGB=0.0324, MLP=0.0679 (match Abstract)
**Flags**: KM at-risk tables not yet added. Recommend for journal revision.

---

## Phase 4 — QA Audit Results

### 4.1 Numerical Integrity: PASS
- LR holdout AUC 0.9939 consistent across Abstract, Table 3, Discussion
- TCGA n=161 calibration confirmed against external_validation.py
- 10-gene signature identical in Abstract and Methods
- Bootstrap uses 1,000 resamples documented in Methods
MINOR FLAG: Random seed 42 should be stated explicitly once in Data Availability section.

### 4.2 README Consistency: PASS
- complete_analysis.py added to repo structure and execution guide
- Metrics updated in README results section

### 4.3 Writing Quality: PASS
- Past tense in Results/Methods, present tense for general truths in Discussion
- All acronyms defined at first use
- Causal language avoided throughout
MINOR FLAG: Abstract is one long paragraph; Genome Medicine uses structured abstracts -- split if required.

### 4.4 Citations: PASS
- 12 references, all have author/year/journal
- 7 new citations added (Task 3.1 and 3.4) all verified as real publications
- DOIs included for new citations
MINOR FLAG: Confirm numbered citation style matches Genome Medicine format.

### 4.5 Reproducibility: PASS
- End-to-end pipeline runs successfully (verified this session)
- All scripts callable via CLI
- GitHub URL included in paper
MINOR FLAG: requirements.txt should be pinned (run pip freeze). Runtime/RAM not documented.

---

## Outstanding Items Requiring Author Decision

1. Structured abstract: Genome Medicine requires Background/Methods/Results/Conclusions format.
2. At-risk tables: Add lifelines add_at_risk_counts() to KM curves for final version.
3. Random seed: Add one sentence to Methods: 'All stochastic computations used random seed 42.'
4. requirements.txt: Run pip freeze to pin exact versions.
5. Runtime note: Add estimated runtime (~5 min, 8GB RAM) to README.
6. Reviewer affiliations: Independently verify before submission.
